THE FDA has approved Dalvance
(dalbavancin), an antibacterial drug
to treat adult skin infections.
Dalvance is the first drug
designated as a Qualified Infectious
Disease Product to receive FDA
approval.The above article was sent to subscribers in Pharmacy Daily's issue from 26 May 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 May 14
THOUGH women make up 60% of pharmacy graduates and pharmacists, they hold only 34% of leadership and ownership roles, according to Andria Aird, a community pharmacist, pharmacy owner, and Board Director of Blooms The Chemist.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.